Advertisement
RLMD vs XENE
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RLMD is a Hold and XENE is a Buy.
RLMD's Indicator enters downward trend
The Aroon Indicator for RLMD entered a downward trend on October 21, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 240 similar instances where the Aroon Indicator formed such a pattern. In 205 of the 240 cases the stock moved lower. This puts the odds of a downward move at 85%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 21, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on RLMD as a result. In 72 of 89 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 81%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where RLMD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 85%.
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where RLMD's RSI Indicator exited the oversold zone, 27 of 33 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 82%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 47 of 58 cases where RLMD's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 81%.
The Moving Average Convergence Divergence (MACD) for RLMD just turned positive on October 20, 2026. Looking at past instances where RLMD's MACD turned positive, the stock continued to rise in 31 of 38 cases over the following month. The odds of a continued upward trend are 82%.
Following a +8.39% 3-day Advance, the price is estimated to grow further. Considering data from situations where RLMD advanced for three days, in 230 of 268 cases, the price rose further within the following month. The odds of a continued upward trend are 86%.
RLMD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 14 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 31 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.658) is normal, around the industry mean (2.988). P/E Ratio (-3.527) is within average values for comparable stocks, (-1.158). Projected Growth (PEG Ratio) (0.120) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (123.903) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (438.009).
The Tickeron Price Growth Rating for this company is 64 (best 1 - 100 worst), indicating steady price growth. RLMD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RLMD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
XENE's MACD Histogram just turned positive
The Moving Average Convergence Divergence (MACD) for XENE turned positive on October 07, 2026. Looking at past instances where XENE's MACD turned positive, the stock continued to rise in 42 of 50 cases over the following month. The odds of a continued upward trend are 84%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where XENE's RSI Indicator exited the oversold zone, 22 of 27 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 81%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 51 of 66 cases where XENE's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 77%.
Following a +8.30% 3-day Advance, the price is estimated to grow further. Considering data from situations where XENE advanced for three days, in 195 of 290 cases, the price rose further within the following month. The odds of a continued upward trend are 67%.
XENE may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The 50-day moving average for XENE moved below the 200-day moving average on October 13, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where XENE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 68%.
The Aroon Indicator for XENE entered a downward trend on October 21, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 10 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 66 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock slightly better than average.
The Tickeron Valuation Rating of 76 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.802) is normal, around the industry mean (2.988). P/E Ratio (-7.584) is within average values for comparable stocks, (-1.158). Projected Growth (PEG Ratio) (1.930) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (123.903) among similar stocks. P/S Ratio (588.235) is also within normal values, averaging (438.009).
The Tickeron Price Growth Rating for this company is 80 (best 1 - 100 worst), indicating slightly worse than average price growth. XENE’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
RLMD | XENE | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 60 | 76 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 31 Undervalued | 76 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 66 | |
SMR RATING 1..100 | 98 | 97 | |
PRICE GROWTH RATING 1..100 | 64 | 80 | |
P/E GROWTH RATING 1..100 | 14 | 10 | |
SEASONALITY SCORE 1..100 | n/a | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
RLMD's Valuation (31) in the null industry is somewhat better than the same rating for XENE (76) in the Biotechnology industry. This means that RLMD’s stock grew somewhat faster than XENE’s over the last 12 months.
XENE's Profit vs Risk Rating (66) in the Biotechnology industry is somewhat better than the same rating for RLMD (100) in the null industry. This means that XENE’s stock grew somewhat faster than RLMD’s over the last 12 months.
XENE's SMR Rating (97) in the Biotechnology industry is in the same range as RLMD (98) in the null industry. This means that XENE’s stock grew similarly to RLMD’s over the last 12 months.
RLMD's Price Growth Rating (64) in the null industry is in the same range as XENE (80) in the Biotechnology industry. This means that RLMD’s stock grew similarly to XENE’s over the last 12 months.
XENE's P/E Growth Rating (10) in the Biotechnology industry is in the same range as RLMD (14) in the null industry. This means that XENE’s stock grew similarly to RLMD’s over the last 12 months.
| RLMD | XENE | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 82% | 2 days ago 81% |
| Stochastic ODDS (%) | 2 days ago 81% | 2 days ago 77% |
| Momentum ODDS (%) | 2 days ago 81% | N/A |
| MACD ODDS (%) | 2 days ago 82% | 2 days ago 84% |
| TrendWeek ODDS (%) | 2 days ago 86% | 2 days ago 72% |
| TrendMonth ODDS (%) | 2 days ago 86% | 2 days ago 71% |
| Advances ODDS (%) | 3 days ago 86% | 3 days ago 67% |
| Declines ODDS (%) | 7 days ago 85% | 9 days ago 68% |
| BollingerBands ODDS (%) | 2 days ago 83% | 2 days ago 77% |
| Aroon ODDS (%) | 2 days ago 85% | 2 days ago 73% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
RLMD’s FA Score shows that 2 FA rating(s) are green while XENE’s FA Score has 1 green FA rating(s).
- RLMD’s FA Score: 2 green, 3 red.
- XENE’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
RLMD’s TA Score shows that 5 TA indicator(s) are bullish while XENE’s TA Score has 5 bullish TA indicator(s).
- RLMD’s TA Score: 5 bullish, 3 bearish.
- XENE’s TA Score: 5 bullish, 3 bearish.
Price Growth
RLMD (@Biotechnology) experienced а -0.93% price change this week, while XENE (@Biotechnology) price change was +6.05% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was -1.10%. For the same industry, the average monthly price growth was -18.18%, and the average quarterly price growth was -15.20%.
Reported Earning Dates
RLMD is expected to report earnings on Nov 12, 2026.
XENE is expected to report earnings on Nov 02, 2026.
Industries' Descriptions
@Biotechnology (-1.10% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
Advertisement
RLMD and
Correlation & Price change
A.I.dvisor indicates that over the last year, RLMD has been loosely correlated with XENE. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if RLMD jumps, then XENE could also see price increases.
| Ticker / NAME | Correlation To RLMD | 1D Price Change % | ||
|---|---|---|---|---|
| RLMD | 100% | -4.46% | ||
| XENE - RLMD | 50% Loosely correlated | -0.88% | ||
| DNTH - RLMD | 40% Loosely correlated | -0.83% | ||
| ANTX - RLMD | 39% Loosely correlated | +1.12% | ||
| RNAC - RLMD | 38% Loosely correlated | +0.39% | ||
| SNDX - RLMD | 38% Loosely correlated | -0.75% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| DTEC | 51.85 | 0.47 | +0.92% |
| ALPS Disruptive Technologies ETF (DTEC) | |||
| XLF | 56.04 | 0.32 | +0.57% |
| State Street Financial Select Sector SPDR ETF (XLF) | |||
| AMZP | 26.01 | 0.03 | +0.11% |
| Kurv Yield Prem Strategy Amazon ETF (AMZP) | |||
| FTF | 5.40 | -0.02 | -0.37% |
| Franklin Limited | |||
| SH | 32.07 | -0.17 | -0.53% |
| ProShares Short S&P500 (SH) | |||